Abstract
Cardiac arrhythmia is a known manifestation of novel coronavirus 2019 (COVID-19) infection. Herein, we describe the clinical course of an otherwise healthy patient who experienced persistent ventricular tachycardia and fibrillation which is believed to be directly related to inflammation, as opposed to acute myocardial injury or medications that can prolong the QT interval.
Copyright © 2020 Elsevier Inc. All rights reserved.
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use
-
COVID-19
-
Coronavirus Infections / complications*
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / therapy
-
Electric Countershock / methods*
-
Electrocardiography / methods*
-
Female
-
Follow-Up Studies
-
Humans
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / therapy
-
Recovery of Function
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome
-
Ventricular Fibrillation / complications*
-
Ventricular Fibrillation / diagnosis
-
Ventricular Fibrillation / diagnostic imaging
-
Ventricular Fibrillation / therapy*